What will the pharma landscape look like after the pandemic is over?
It's a point of time that appears forever on the near-distant horizon...
That massive change has taken place is unquestionable. But how much of it is permanent, and what further changes are yet to come? Will the new normal be better or worse than the old normal? Who will benefit from the changes, and who will not?
As an agency that has supported the pharma industry for more than twenty years, we wanted to address these questions for two reasons.